BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 4th Quarter - Report

LIBERTY HEALTH SCIENCES

via BGR GOVERNMENT AFFAIRS

4th Quarter (Oct 1 - Dec 31) · 2017Posted Jan 22, 2018Filing document ↗LDA record ↗

Income$80Kfee reported

Client

Name: LIBERTY HEALTH SCIENCES
Description: Medical & Agriculture
Location: Canada

Registrant

Firm: BGR GOVERNMENT AFFAIRS
Description: Lobbying firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Agriculture
Provide guidance and strategic counsel on potential commerce, justice, science and related agencies policies, legislation/regulations, and/or appropriations that may impact the Company.
Lobbyistsmr DANIEL R MURPHY · PETE LANDRUM
Covered position (mr DANIEL R MURPHY): See prior filing
Covered position (PETE LANDRUM): See prior filing
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

LIBERTY HEALTH SCIENCES — Lobbying — Receipts Report